Musing on Mathew et al.
Kaniecki
Robert G
RG
D002214:Capsules; D002986:Clinical Trials as Topic / Q000592:standards*; D004311:Double-Blind Method; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008881:Migraine Disorders / Q000188:drug therapy*; D011446:Prospective Studies; D011759:Pyrrolidines / Q000627:therapeutic use*; D012107:Research Design / Q000592:standards*; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use*; D018170:Sumatriptan / Q000627:therapeutic use*; D014363:Tryptamines
D002214:Capsules; D007211:Indoles; D011759:Pyrrolidines; D017366:Serotonin Receptor Agonists; D014363:Tryptamines; C115647:eletriptan; D018170:Sumatriptan